Position in INSM
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,984,793
-$3,978,480 QoQ
Shares Held
56,132
-7.9% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#197
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Resona Asset Management Co.,Ltd. holds $108,055,256 across 14 Biotechnology names. INSM ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
84,092 | $41,771,019 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,289 | $18,886,403 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
40,053 | $12,057,154 | |
| 4 | INCY |
Incyte Corp
|
78,119 | $8,855,569 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
43,260 | $8,101,732 | |
| 6 | RPRX |
Royalty Pharma plc
|
109,991 | $6,167,195 | |
| 7 | INSM |
INSMED Inc
This page
|
56,132 | $5,984,793 | |
| 8 | EXEL |
Exelixis, Inc.
|
38,594 | $2,099,899 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,984,793 | 56,132 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $9,963,273 | 60,930 | Shares | Other | 2026-04-30 | |
| 2025-12-31 | $10,508,709 | 60,381 | Shares | Other | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||